SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive analyst upgrade that highlights the company's progress in regulatory pathways and validates the therapeutic potential of its lead candidate, Sonelokimab. Investors are actively discussing the stock's significant long-term growth prospects, the potential for a strategic buyout, and the upcoming clinical data readouts that are expected to solidify the drug's position as a best-in-class treatment.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following a series of significant Department of Defense and defense-contractor awards, which have sparked intense community debate over the company's long-term production scalability and balance sheet health. While bulls point to these mission-critical manufacturing contracts as validation of the company's technology, short-sellers and skeptical investors remain focused on ongoing cash burn concerns and the potential for future equity dilution.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is facing intense volatility as shareholders grapple with the end of a major lock-up period and skepticism following a disappointing earnings report that revealed a lack of near-term tenant revenue. The community is sharply divided, with some investors aggressively calling for leadership changes and reporting the firm to the SEC, while others view the current price drop as a strategic buying opportunity in anticipation of future data center power demand.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors gear up for the upcoming fiscal year-end and 10-K filing, with the community highly focused on QNX revenue growth, backlog expansion, and the impact of the new Alloy Kore platform. Shareholders are actively debating management's guidance and the potential for a long-awaited breakout as they look for concrete signs of sustainable double-digit growth.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors weigh strong AI licensing potential and institutional backing against lingering concerns over platform monetization and data integrity. While community members debate whether the stock is a long-term growth play or currently oversold, high-profile litigation updates regarding content scraping continue to fuel active discussion about the company's valuation.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is trending following positive trial data from its TETON-1 study, which demonstrated that nebulized Tyvaso significantly preserves lung function in patients with idiopathic pulmonary fibrosis. The community is actively discussing the potential for a major label expansion that could triple the addressable market for the therapy, leading to multiple analyst price target increases as the company prepares for an FDA submission.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community leans into its roots as a foundational internet meme, bolstered by the restoration of its original RageBuilder and Ragemaker tools. Enthusiasts are actively rallying around the project as a long-term culture play, emphasizing organic growth and community-driven content production as they target long-term valuation milestones.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened trading activity as the company's recent operational updates and offtake agreements drive significant investor interest, leading to strong buying momentum in the stock. The community is actively debating the stock's potential for a breakout, with many discussing the impact of lithium supply-demand dynamics and monitoring insider buying as a key indicator of confidence in future growth.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as the community debates its future following a major strategic shift to discontinue its Aortic Valve Systems, which has sparked discussions about potential impact on long-term margins and resource allocation. Meanwhile, investors are closely monitoring the stock's resilient momentum and recent bullish analyst outlooks that emphasize strong growth in the company's cardiovascular and electrophysiology segments.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing significant downward pressure following the release of phase 3 clinical trial data for its thyroid eye disease drug, elegrobart, which failed to demonstrate the level of efficacy compared to IV-based treatments that investors had hoped for. While management emphasizes the drug's safety profile and ongoing clinical progress, market participants are actively debating the competitive threat from established standards of care and potential future rivals, leading to increased volatility and a sharp decline in share price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KRISPY KREME Launches Artemis II Doughnut to Celebrate NASA's Historic Deep Space Crewed Mission, Available March 31 April 2

The dream of enjoying Krispy Kreme doughnuts on the Moon is about to take a giant leap forward, and were all about it! This press release features multimedia. View the full release here...

Krispy Kreme (NASDAQ:DNUT) Raised to "Overweight" at Capital One Financial

Capital One Financial raised Krispy Kreme from an "equal weight" rating to an "overweight" rating and set a $6.00 target price for the company in a research note on Thursday...

Krispy Kreme, Inc. (NASDAQ:DNUT) Receives Average Recommendation of "Reduce" from Brokerages

Krispy Kreme, Inc. (NASDAQ:DNUT - Get Free Report) has been given a consensus rating of "Reduce" by the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, five have given a hold recommend...

Rep. Tim Moore Sells Off Shares of Krispy Kreme, Inc. (NASDAQ:DNUT)

Representative Tim Moore (Republican-North Carolina) recently sold shares of Krispy Kreme, Inc. (NASDAQ:DNUT). In a filing disclosed on March 24th, the Representative disclosed that they had sold between $15,001 and $50,000 in Krispy Kreme stock on March 17th. Representative Tim Moore also recently...

Krispy Kreme (NASDAQ:DNUT) Stock Price Down 4%  - Time to Sell?

Krispy Kreme (NASDAQ:DNUT) Trading Down 4% - What's Next...

Krispy Kreme Advances Turnaround to Drive Capital-Light Growth Through Refranchising

Krispy Kreme, Inc. (NASDAQ: DNUT) (Krispy Kreme, KKI, or the Company) today announced continued progress on its turnaround plan to deleverage the balance sheet and drive sustainable, profitable growth through refranchising, a key component of the plan. WKS Restaurant Group Increases Stake in...

ARKO (ARKO) Moves 6.8% Higher: Will This Strength Last?

ARKO (ARKO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

The Hunt is Over! KRISPY KREME is Filling Baskets with Egg-cellent New Easter Doughnuts

Your hunt for the perfect Easter treats ends here! Krispy Kreme is introducing a new Easter Basket Collection packed with playful, flavorful doughnuts youll want to grab fast and share even faster...

KRISPY KREME Sweetens Hoops Hysteria with New Bracket Bash Dozen Beginning Thursday, March 19

With bracket season tipping off, Krispy Kremes new Bracket Bash Dozen is a buzzer-beater sure to win with your squad. This press release features multimedia. View the full release here...

Krispy Kreme (NASDAQ:DNUT) Shares Up 7.4% - What's Next?

Krispy Kreme (NASDAQ:DNUT) Shares Up 7.4% - Still a Buy...

Krispy Kreme, Inc. produces and distributes doughnuts. It offers yeast-raised doughnuts, pies, coffees and espresso drinks, chillers and iced beverages. It operates through the following segments: U.S. and Canada, International, and Market Development. The U.S. and Canada segment includes all Krispy Kreme’s company-owned operations in the U.S. and Canada, Insomnia-branded retail shops and consumer packaged goods operations. The International segment consists of all Krispy Kreme's company-owned operations in the United Kingdom, Ireland, Australia, New Zealand, and Mexico. The Market Development segment handles the franchise operations across the globe, as well as Krispy Kreme company-owned shops in Japan. The firm sells its products through mass merchant, grocery and convenience stores. The company was founded in 1937 and is headquartered in Charlotte, NC.

Krispy Kreme Inc

Fred Wilson - Union Square Ventures

Abigail Johnson - Fidelity

Jim Cramer - Media Personality

Josh Brown - Ritholtz Wealth Management

A lifetime achievement for industry titans. This honor is reserved for an individual whose groundbreaking contributions have shaped the investing landscape and how we engage with the markets.

DNUT
Krispy Kreme Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DNUT News

DNUTKrispy Kreme Inc